PFF In The Media

Accurate and Timely Diagnosis Crucial for Those With Pulmonary Fibrosis

Pulmonary fibrosis is a progressive, debilitating lung disease that scars the lung tissue, and affects more than 200,000 Americans. A timely diagnosis is crucial for treatment.

Link to Article

Diagnosis Can Be Missed When Breathing Is the Issue

Valeria Hatcher knew something was wrong when she began getting winded just walking short distances and going up stairs, so the 48-year-old went to see her doctor. But like many individuals with PF, Hatcher’s journey with the disease began with a misdiagnosis.

Link to Article

Clinical Trials Day: Empowering Patients to Participate in Active Pulmonary Fibrosis Trials

Clinical trials continue to serve as a critical component in drug development — especially in the PF sector.

Link to Article

The Role of Air Pollution in Pulmonary Fibrosis

To mark Clean Air Month, the Pulmonary Fibrosis Foundation aims to increase public understanding of the role air pollution has in the development of interstitial lung diseases (ILD) such as pulmonary fibrosis, including how polluted air can make you sick and the telltale signs to be aware of.

Link to Article

National Pulmonary Fibrosis Foundation Walk approaches

Take one step forward in the search for a cure and walk with us! Join patients, families and friends from coast to coast and bring the spirit of the PFF Walk to your community on National Walk Day on Sept. 25.

Link to Article

West Hartford Residents and Local Educators Walk a Million Miles for Pulmonary Fibrosis Research

West Hartford resident Mal Doyle and his daughter, Valerie Hansen, raised more than $11,000 – and counting – from their recent Steps for Better Breathing Walk in support of Mal and the Pulmonary Fibrosis Foundation.

Link to Article

The Deadly Lung Disease You've Probably Never Heard Of

Pulmonary fibrosis (PF) is an uncommon and frequently fatal lung disease, and the road to diagnosis can be long and difficult.

Link to Article

Early Diagnosis for Pulmonary Fibrosis is Key

Pulmonary fibrosis (PF) continues to be relatively unknown among the public, making awareness and education critically important.

Link to Article

Local pulmonary fibrosis ambassador goes to Washington

On March 10, Debbie Herndon, Boise resident and ambassador for the Pulmonary Fibrosis Foundation, traveled (virtually) to Washington, D.C., with a group of fellow advocates from around the country to drive awareness and research funding for the disease.

Link to Article

Learn the Symptoms of Pulmonary Fibrosis this Rare Disease Day

One in 20 people will live with a rare disease at some point in their life*. Rare Disease Day, celebrated annually on February 28, provides an opportunity to raise awareness for diseases that are not well known, such as pulmonary fibrosis (PF).

Link to Article

My Breath, Made Possible by Another: Lung Transplants and Pulmonary Fibrosis

According to the Organ Procurement and Transplantation Network, a patient in need of a life-saving organ transplant is added to the national waiting list every 9 minutes*.

Link to Article

The pulmonary fibrosis treatment landscape: An interview with an expert

In 2014, FDA approved two medications for idiopathic pulmonary fibrosis (IPF) — nintedanib from Boehringer Ingelheim and pirfenidone from Roche (OTCMKTS:RHHBY).

Link to Article

PFF Patients Advocate and Inspire for National Patient Recognition Week

Sharing patient stories can help spread awareness for little-known diseases like pulmonary fibrosis, empowering patients to build support systems, pinpoint symptoms and take action early.

Link to Article

Resolve to talk to your doctor in the New Year

The New Year is the perfect time to advocate for your health and commit to listening to your body for any new symptoms or warning signs.

Link to Article

There’s No Place Like Home for the COVID Holidays

It’s hard to believe, but the holiday season is upon us. In any other year, we’d be readying holiday plans for parties and get-togethers with family and friends, but this year is different.

Link to Article

What You Should Know About Pulmonary Fibrosis

Have you heard of pulmonary fibrosis? If you answered no, you are not alone.

Link to Article

Know these Pulmonary Fibrosis Risk Factors

October is Healthy Lung Month, an apt time to educate the public about the importance of protecting our lungs against mold, airborne pollutants and smoking – which put hundreds of thousands of Americans at higher risk for pulmonary fibrosis (PF).

Link to Article

Clinical Challenges: Diagnosing Idiopathic Lung Fibrosis

Approval of two antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) -- pirfenidone (Esbriet) and nintedanib (Ofev) -- represented a paradigm shift in the management of the progressive fibrotic disease and potentially other interstitial lung diseases, ushering in the era of therapies that can slow lung scarring progression.

Link to Article